기업 프로필 · Healthcare

Bruker Corporation

BRKR · 미국
거래소
미국
국가 / 지역
USA
상장일
2000년 8월 4일
직원 수
11,085
웹사이트
www.bruker.com
현재가
$54.73
실시간 · 2026년 6월 18일
적정 매수가
≤ $48
안전마진 진입가
베일리 성장 점수
41/100
다소 약함
내재가치 · 3단계 구간 현재가 $54.73 실시간 · 적정 내재가치 구간 내

종합 밸류에이션 구간 · 보수적 $35–$45 / 적정 $48–$60 / 낙관적 $68–$85. $54.73 기준, 적정 내재가치 구간 내.

보고서 발행 시 $59.97(2026년 6월 4일)

이 종목에 대한 리포트가 아직 해당 언어로 없습니다.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

시가총액US$83.31억
매출 (TTM)US$34.59억
EBITDAUS$4.89억
순이익률-0.34%
ROE-0.43%
선행 PER15.22
PEG1.52
EPS-US$0.24
배당수익률0.36%
52주 범위US$28.41 – US$64.54
애널리스트 목표주가US$53.25
애널리스트 평가3.9 / 5

데이터 제공: EODHD, 보고 통화 기준 표시. 참고용일 뿐 투자 자문이 아닙니다.

연혁

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

업계 내 위치

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.